Tidewave Bio, a biotechnology company developing a universal, biopsy-native immunotherapy platform for solid tumors, today announced the appointment of Prof. Alexander M.M. Eggermont, MD, PhD, as Head ...

Researchers are engineering bacteria to invade tumors and consume them from the inside. Because tumor cores lack oxygen, they ...

Building an AI infrastructure for biotech. Bacteria that munch on cancer. How to best make a cold brew. All that and more in ...

A research team led by Professor Ki-Young Lee at the College of Medicine, Sungkyunkwan University, has uncovered a previously unrecognized tumor-intrinsic role of the immune checkpoint molecule PD-L1, ...

Dr. Anczukow is a leading cancer biologist with expertise in RNA biology, molecular and cell biology, as well as human genetics, cancer biology, and genomics ...

Advancing Research, Awareness, and Targeted Youth Advocacy for Women Diagnosed with Breast Cancer Before Age 40 DENVER, ...

Excerpted with permission from the publisher The Emperor of All Maladies: A Biography of Cancer (Revised Edition, 2026), Siddhartha Mukherjee, published by Fourth Estate, HarperCollins India.

Shifting the focus from organ to biomarker has unlocked new options for rare and advanced cancers. Uneven efficacy, diagnostic access, and regulation still slow clinical rollout.

A research team led by the University of Waterloo is developing a novel tool to treat cancer by engineering hungry bacteria to literally eat tumors from the inside out. "Bacteria spores enter the ...

Hidden within cancer DNA data, researchers uncovered viruses and bacteria that may influence both diagnosis and survival.

BioNTech and partner DualityBio are accelerating the development of their B7-H3 antibody-drug conjugate into a phase 3 trial for metastatic castration-resistant prostate cancer (mCRPC). | BioNTech and ...

Irish and American researchers have identified a potential new way to counter treatment‑resistant prostate cancer by ...